Clinical Trial Update: Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports ongoing Phase 1/2 testing of allogeneic HB-adMSCs versus placebo for acute kidney injury, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Allogeneic HB-adMSCs (HB-adMSCs)

Snippet

Sponsor: Hope Biosciences LLC | Conditions: Acute Kidney Injury | Phase 1, Phase 2 | Status: RECRUITING